Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
When it comes to pharmaceuticals expenditure, the National Commission of Audit’s proposals rate highly on any policy change scale. Its two main recommendations are designed to reduce the overall cost to…
Last week, Treasurer Joe Hockey made a “case for change” in the way government spends money. His focus was largely on macro policy settings, such as pension entitlements, including access to schemes such…
Generic drugs are copies of brand-name drugs whose patent has expired, allowing consumers (and governments) to buy a replica drug at a fraction of the price. But a recent US investigation has found consumers…
The Consumers Health Forum has just launched a website containing information about the cost of generic drugs in Australia compared to other countries. Each day, Australians pay A$3 million more for these…
HEALTH RATIONING – a series which examines Australia’s rising health costs and the tough decisions governments must make to rein them it. Any mention of the “R” word in health care immediately brings to…
A growing number of people globally live with chronic illness. By the time they reach 65, most Australians have at least one chronic condition and 80% have three or more. Pharmaceutical treatment is often…
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne